SEPN Septerna Inc.

  1. Stocks
  2. Healthcare
  3. NASDAQ: SEPN

Price (delayed)

$31.31

Market cap

$1.41B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.81

Enterprise value

$1.36B

?
Relative Growth: Rel. Growth: 63
Relative Strength: Rel. Strength: 90
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 47

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform ...

Highlights
The revenue has soared by 57% QoQ
The company's gross profit has surged by 57% QoQ
Septerna's quick ratio has shrunk by 86% YoY
SEPN's equity is down by 5% year-on-year
Sector: Healthcare
Industry: Biotechnology
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of SEPN

SEPN stock price

How has the Septerna stock price performed over time
Intraday
2.49%
1 week
0.84%
1 month
26.15%
1 year
214.04%
YTD
12.3%
QTD
30.3%

Financial performance

How have Septerna's revenue and profit performed over time
Revenue
$72.26M
Gross profit
$72.26M
Operating income
-$55.69M
Net income
-$36.04M
Gross margin
100%
Net margin
-49.9%
The net margin has surged by 99% year-on-year and by 53% since the previous quarter
Septerna's operating margin has soared by 99% YoY and by 48% from the previous quarter
The revenue has soared by 57% QoQ
The company's gross profit has surged by 57% QoQ

Price vs fundamentals

How does SEPN's price correlate with its fundamentals

Growth

What is Septerna's growth rate over time

Valuation

What is Septerna stock price valuation
P/E
N/A
P/B
3.72
P/S
19.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.85
The EPS has grown by 38% YoY and by 26% from the previous quarter
SEPN's P/B is 51% higher than its last 4 quarters average of 2.4
SEPN's equity is down by 5% year-on-year
SEPN's P/S is 90% below its last 4 quarters average of 180.6
The revenue has soared by 57% QoQ

Efficiency

How efficient is Septerna business performance
The ROS has soared by 99% YoY and by 54% from the previous quarter
The ROE has soared by 80% YoY and by 25% from the previous quarter
SEPN's ROIC has soared by 79% year-on-year and by 38% since the previous quarter
The ROA has soared by 74% YoY and by 31% QoQ

Dividends

What is SEPN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SEPN.

Financial health

How did Septerna financials performed over time
SEPN's total assets is 198% more than its total liabilities
Septerna's quick ratio has shrunk by 86% YoY
The current ratio has dropped by 85% year-on-year
The debt is 94% smaller than the equity
The debt has declined by 8% year-on-year and by 2.3% since the previous quarter
SEPN's equity is down by 5% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.